Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.
Redox Biol. 2023 Jun;62:102686. doi: 10.1016/j.redox.2023.102686. Epub 2023 Mar 21.
Redox Biol. 2023.
PMID: 36963289
Free PMC article.
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Wen YC, Tram VTN, Chen WH, Li CH, Yeh HL, Thuy Dung PV, Jiang KC, Li HR, Huang J, Hsiao M, Chen WY, Liu YN.
Wen YC, et al. Among authors: thuy dung pv.
Cell Death Dis. 2023 May 4;14(5):304. doi: 10.1038/s41419-023-05836-7.
Cell Death Dis. 2023.
PMID: 37142586
Free PMC article.
Item in Clipboard
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Wen YC, Tram VTN, Chen WH, Li CH, Yeh HL, Thuy Dung PV, Jiang KC, Li HR, Huang J, Hsiao M, Chen WY, Liu YN.
Wen YC, et al. Among authors: thuy dung pv.
Cell Death Dis. 2024 Jan 29;15(1):92. doi: 10.1038/s41419-023-06363-1.
Cell Death Dis. 2024.
PMID: 38287005
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite